10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

Rhea-AI Summary

10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, has announced it will release its fourth quarter and full year 2024 financial results after market close on February 12, 2025. The company will hold a conference call and webcast for analysts and investors at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day.

The financial results will be available on the company's website before the conference call. Investors can access the live webcast through the 'Investors' section of 10x Genomics' website, where it will remain available for replay for at least 45 days following the event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLEASANTON, Calif., Jan. 28, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2024 after market close on Wednesday, February 12, 2025. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter). 

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-12-2025-302362387.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics (TXG) release Q4 2024 earnings?

10x Genomics will release its Q4 and full year 2024 financial results after market close on February 12, 2025.

What time is the 10x Genomics (TXG) Q4 2024 earnings call?

The earnings conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on February 12, 2025.

How can I access the 10x Genomics (TXG) Q4 2024 earnings webcast?

The earnings webcast can be accessed through the 'Investors' section of the company's website at investors.10xgenomics.com.

How long will the 10x Genomics (TXG) Q4 2024 earnings webcast be available for replay?

The webcast will be archived and available for replay for at least 45 days after the event.